Ropinirole Case Report Form GSK RRL100013 GSK Study ID: 100013 Clinical Study ID: RRL100013 A 12-Week, Double-Blind, Placebo-Controlled, Twice-Daily Dosing Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Requiring Extended Treatment Coverage

Versions (4) ▾
  1. 10/5/17
  2. 2/22/18
  3. 2/22/18
  4. 2/22/18
Copyright Holder:
Uploaded on:

February 22, 2018

No DOI assigned. To request one pleaselog in.
Creative Commons BY-NC 3.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Ropinirole Case Report Form GSK RRL100013


Investigational Product
Planned timepoint
Has the subject missed investigational product for >2 consecutive days